NFE2L2 and kidney disorder: PPARG and NRF2 antagonize the transcriptional activity of proinflammatory factor NFκB and have protective activity in renal diseases (Guerrero‐Hue et al., 2020; Li et al., 2008; Ruan et al., 2008; Stenvinkel et al., 2021).